KalshiComprobar disponibilidadKYC requerido2% de comisiónDatos de resolución verificadosCalibración aceptableProbabilidad implícita actual
BPC-157 79%Líder entre 7 opciones
Calidad del mercado
41 / 100
Baja calidadVolumen 24h
—
Liquidez
999,6 €
Baja liquidezSpread
4.0 pt
Spread moderadoDatos de mercado
Actualizado hace 5 minutos
28 jul 26, 16:30 UTC1 oct 27, 3:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Miami-Dade WASD ceases adding fluoride to its drinking water by 2027
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiWhat will Trump say during his announcement on healthcare?
KalshiHeidi Overton confirmed as FDA Commissioner by which date?
PolymarketHantavirus vaccine in 2026?
PolymarketReglas
If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Liquida mediante:U.S. Food and Drug Administration
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add KPV (free base) or KPV acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add TB-500 (free base) or TB-500 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add MOTS-c (free base) or MOTS-c acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Semax (free base) or Semax acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Epitalon (free base) or Epitalon acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de Which peptides will the FDA propose adding to the 503A Bulks List??
- Kalshi cotiza BPC-157 al 79% a fecha de 18 de septiembre de 2026.
- ¿Cuándo se resuelve Which peptides will the FDA propose adding to the 503A Bulks List??
- Está previsto que Which peptides will the FDA propose adding to the 503A Bulks List? se resuelva el 1 de octubre de 2027.
- ¿Cómo se liquida Which peptides will the FDA propose adding to the 503A Bulks List??
- Kalshi liquida este mercado del siguiente modo: If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.